Want to join the conversation?
$LLY lowered its 2016 EPS guidance to range of $2.83-2.93 from previous forecast of $2.92-3.02. $LLY still expects 2016 non-GAAP EPS of $3.45-3.55, which exclude amortization of intangibles as well as integration costs associated with Novartis Animal Health acquisition. $LLY still sees 2016 revenue of $20.2-20.7Bil.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.